Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) For research use only.
Not for use in humans.

Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134)

Synonyms:

Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) is a monoclonal antibody targeting TNFRSF4. MW : 145.5 KD.

Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134)

Purity & Quality Control

Batch: A232501 Purity: 99% Protein concentration: 3.23mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) is a monoclonal antibody targeting TNFRSF4. MW : 145.5 KD.

Product Details

Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) | Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) supplier | purchase Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) | Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) cost | Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) manufacturer | order Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) | Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) distributor